
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Spain breaks jobs record with 22 million Social Security contributors - 2
Man Charged for Stealing ‘Incredibly Precious’ 286-Year-Old Violin, Worth More Than $200,000, from a Tavern - 3
US FDA approves Kura-Kyowa's blood cancer therapy - 4
Computerized Domains d: A Survey of \Vivid Undertakings\ Computer generated Reality Game - 5
Top 20 Wellbeing and Wellness Applications for a Sound Way of life
Brexit's Effect on New York's Ascent as a Main Monetary Center
Step by step instructions to Show Children the Significance of Appropriate Handshaking
Smooth countdown continues for Artemis II moon mission
High Court freezes government move to shutter Army Radio pending ruling
41 Young Men Die in South Africa After Circumcision Initiation
Ukraine confirms defence and energy ministers at second attempt
Best Wellness Tracker Keep You On target
Clocks to go forward one hour in Europe as summer time starts
Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique













